Avecho Biotechnology Ltd - A positive Phase III interim analysis
Avecho Biotechnology Limited (ASX:AVE) is an Australian biotech company currently focused on a CBD (Cannabidiol) soft-gel capsule for insomnia. It...
101 Views
Avecho Biotechnology Ltd - Phase III interim analysis due June 2026
Avecho Biotechnology Limited (ASX:AVE) is an Australian biotech company focused on enhancing drug absorption through its proprietary TPM...
206 Views
Avecho Biotechnology Ltd - Waking the sleeping giant
Avecho Biotechnology Limited (ASX:AVE) is an Australian biotech company focused on enhancing drug absorption through its proprietary TPM...
271 Views
No more insights